This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights: Target, Hain Celestial, Celsius Holdings and Medifast
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Target, Hain Celestial, Celsius Holdings and Medifast
Medifast (MED) Lined Up for Q4 Earnings: Key Things to Note
by Zacks Equity Research
Medifast's (MED) fourth-quarter 2020 results are likely to reflect strength in OPTAVIA, thanks to consumers' growing inclination toward health and wellness.
E-commerce Drives Grocery Sales in January: 4 Stocks to Buy
by Ritujay Ghosh
Although retailers have been struggling, grocery stocks like Target Corporation (TGT) and The Hain Celestial Group, Inc. (HAIN) have been benefiting since the coronavirus outbreak.
Hormel Foods (HRL) Q1 Earnings Beat Estimates, Sales up Y/Y
by Zacks Equity Research
Hormel Foods' (HRL) first-quarter fiscal 2021 results reflect higher net sales driven by growth across all segments. However, earnings fell year over year.
General Mills (GIS) Poised on High Demand, Accelerate Strategy
by Zacks Equity Research
General Mills (GIS) is witnessing rising demand owing to higher at-home consumption amid COVID-19. Also, its recently-unveiled Accelerate strategy looks impressive.
Hormel Foods (HRL) on Track With Product Launches to Aid Growth
by Zacks Equity Research
Hormel Foods' (HRL) Hormel pretzel bites and cheese tray launch is likely to boost assortment strength and help it cater to growing snack demand.
Use DuPont Analysis to Pick 5 Top-Ranked Quality Stocks
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
Sysco's (SYY) Innovative Concepts to Aid Foodservice Operators
by Zacks Equity Research
Sysco (SYY) launches nine innovative concepts through its Cutting Edge Solutions platform to help foodservice operators amid challenging operating environment.
Flowers Foods (FLO) Q4 Earnings Surpass Estimates, Sales Up
by Zacks Equity Research
Flowers Foods' (FLO) fourth-quarter fiscal 2020 results reflect higher sales and earnings, courtesy of strength across branded retail business.
Kellogg (K) Q4 Earnings Miss Estimates, Sales Increase Y/Y
by Zacks Equity Research
Kellogg's (K) fourth-quarter 2020 results reflect year-over-year decline in earnings per share. Nonetheless, organic sales increase on the back of growth in all regions.
Molson Coors' (TAP) Q4 Earnings Miss Estimates, Decline Y/Y
by Zacks Equity Research
Molson Coors (TAP) reports dismal fourth-quarter 2020 results, with earnings and sales lagging the estimates. Higher costs and lower sales hurt the bottom line.
Hain Celestial's (HAIN) Q2 Earnings Beat on Higher Margins
by Zacks Equity Research
Smooth execution of transformation plan aided Hain Celestial's (HAIN) second-quarter fiscal 2021 performance. It expects sustained margin growth for fiscal 2021.
Philip Morris (PM) Q4 Earnings Beat Estimates on Solid Pricing (Revised)
by Zacks Equity Research
Philip Morris' (PM) fourth-quarter 2020 results reflect solid pricing variance, mainly owing to elevated combustible pricing. However, soft cigarette shipment volumes hurt revenues.
Philip Morris (PM) Q4 Earnings Beat Estimates on Solid Pricing
by Zacks Equity Research
Philip Morris' (PM) fourth-quarter 2020 results reflect solid pricing variance, mainly owing to elevated combustible pricing. However, soft cigarette shipment volumes hurt revenues.
Hershey's (HSY) Q4 Earnings Surpass Estimates, Sales Up
by Zacks Equity Research
Hershey's (HSY) fourth-quarter 2020 results reflect higher sales and earnings on strength across the North America segment.
Sysco's (SYY) Q2 Earnings & Sales Lag Estimates, Decline Y/Y
by Zacks Equity Research
Sysco's (SYY) second-quarter fiscal 2021 results reflect declines in the top and bottom lines due to the prevalent unfavorable impacts of the pandemic.
Zacks.com featured highlights include: Medifast, 1800 FLOWERS, Marine Products, AllianceBernstein Holding and Robert Half International
by Zacks Equity Research
Zacks.com featured highlights include: Medifast, 1800 FLOWERS, Marine Products, AllianceBernstein Holding and Robert Half International
Depend on DuPont to Buy 5 Top-Ranked Healthy Stocks
by Sanghamitra Saha
Why you should depend on the DuPont technique to pick solid profit-generating stocks.
Strong Brands to Keep Hain Celestial (HAIN) Cheering in 2021
by Zacks Equity Research
Hain Celestial (HAIN) gains from strong brand penetration across North America and International segments. Markedly, at-home dining trends are adding gleam to the stock.
Kellogg's (K) MorningStar Farms & Dunkin' Launch Meatless Sandwich
by Zacks Equity Research
Kellogg's (K) MorningStar Farms teams up with Dunkin' to introduce a meatless yet flavorful product ¿¿¿ the Southwest Veggie Power Breakfast Sandwich.
The Zacks Analyst Blog Highlights: B&G Foods, Hain Celestial, Medifast and United Natural Foods
by Zacks Equity Research
The Zacks Analyst Blog Highlights: B&G Foods, Hain Celestial, Medifast and United Natural Foods
4 Food Stocks Up More Than 50% in 2020 With Room to Grow
by Vrishali Bagree
Several food companies are gaining on higher at-home consumption amid the pandemic. Also, focus on innovation and other brand-building efforts has been backing growth for B&G Foods (BGS), Hain Celestial (HAIN), Medifast (MED) and United Natural (UNFI).
The Zacks Analyst Blog Highlights: MACOM Tech, CrowdStrike, Zscaler, CareDx and Medifast
by Zacks Equity Research
The Zacks Analyst Blog Highlights: MACOM Tech, CrowdStrike, Zscaler, CareDx and Medifast
Smucker (SJM) Gains on Pandemic-Led Demand, Cost Concerns Stay
by Zacks Equity Research
Smucker (SJM) has been gaining on increased demand owing to the pandemic-led higher at-home consumption. However, the company expects a rise in SD&A expenses in fiscal 2021.
5 Stocks With Unstoppable Growth to Buy in 2021
by Rajani Lohia
Investing in stocks which have outpaced the market in 2020, defying the impacts of the COVID-19 outbreak, and have the potential for greater returns in 2021 is advisable.